ผลการรักษามะเร็งเต้านมแบบสงวนเต้า ของศูนย์มะเร็งลำปาง ปี 2540-2546
Abstract
Purpose : To evaluate the treatment outcomes and treatment related complication after conservative therapy (BCT).
Material and method : Retrospective analysis was performed on 45 patients treated between 1998 and 2003 in Lampang cancer center. The patients were analyzed to determine survival. Analysis was perform with Kaplan-Meier estimates.
Result : At median follow up of 46 months. 2 patients had an ipsilateral breast tumor recurrence. The 5 year overall survival and disease free survival rate of these patients were 95.6 % and 97.1965, respectively.
Conclusion : To compare the result of treatment outcome and treatment related complications after BCT in Lampang cancer center with other centers, the result was acceptable.
References
Cancer in Thailand Vol. III 1995-1997.
Cancer incidence and Mortality in Lampang, Thailand Vol. III 1998 - 2002, Hospital - Based cancer registry, ปี 2547
Fowble BL: Breast conserving therapy for early stage invasive cancer 39 Annual Meeting.ASTRO,October 1997, No 417
Veronesi U, Ban fi A, Salvadori B, et al : Breast conservation in the treatment of choice in small breast cancer : Long term results of randomized trial, Eur J Cancer 1990; 26 : 668 - 670
Sarragin D, Le MG, Aniagada R, et al: Ten-year results of a randomized trial comparing a conservative treatment to mastectomy is early breast cancer. Radiation Oncol 1989;14 : 177 - 184
Fisher B. Anderson S, Redmond CO,et at al : Re analysis and result after 12 years of follow up in 9 randomized Clinical trial comparing total mastectomy with lumpectomy with or without iradiation in the treatment of breast cancer N Engl J Mod 1995; 333 : 1456
Morris AD, Moris RD, Wilson JF, et al : Breast conserving therapy VS mastectomy in early breast cancer : a meta - analysis of 10-years survival cancer I Sei Am 1977; 3 : 6-12
Van Donger JA, Voogd AC, Fentiman IS, et al : Long term results of a randomized trial comparing breast conserving therapy with mastectomy BORTC 10801 trial. J Natl Cancer Inst 2000; 92: 1143-1150
Blichert - TM, Rose C, Anderson JA, et al. Danish randomized trial comparing breast conserving therapy with mastectomy: DBCG-J Nati Cancer Inst Monogr 1992; 11: 19-25
LihegrenG. Holmbeg L, Adami H.O, et al: sector resection with or without postopendive radiotherapy: Five year result of a randomized trial. I nati cancer Inst 194; 86:717
Clark RM, Whelan T, Levine M, et al: Randonized clinical trial of breast irration following lumpectomy and axillary dissection for nede negative breast cancer. An update Jnatl Cancer Inst 1998; 88: 105
Van panger JA, Bantelink H, Fentiman IS , et al : Randomized clinical trial to cosess the value of breast conserving therapy in stage I and II breast EORIC 10801 trial. I Natl cancer Inst Monogr 1992; 11: 15.
Park CC, Mitsumoxi M, Niscon A, et al. Outcome at 8 year after Bes and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. I Clin. Oncol 2000 :18 : 1668 - 1675
Gage I, Shnitt SJ, Nixon AJ, et al. Pathologic margin involvement and the risk of recurrence in patients treated with BCT.cancer 1996, 78: 1921 - 1928
Smitt MC, Nowels RW, Zdelstick MJ, et al. the importance of the lumpectomy surgical margin status in long-term results of breast conservation cancer 1995, 76: 259 - 267
Komamicky LT, mansfield CM, Dibiase SJ Prognostic significance of the number of positive margin in breast conserving treatment for early stage breast cancer. Cancer J Sci Am 1997; 3 : 119
Phihp Poortmans, Harry Bartclink, Jean - Claude Horiot et - al., The influence of the boost technique on local control in breast conserving treatment in the EORTC boost version no breast randomized trial, Radiotherapy and Oncology , Vol 72 , Issue 1, July 2004, page 25- 33
Polgan C, Fodox I, Orosz Z et al, Electron and high - dose - rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first result of randomized Budapest boost trial. Strahlenther Onkol. 2002 Nov; 178 (11): 615 - 23
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของวารสารมะเร็งวิวัฒน์ ข้อความที่ปรากฏในบทความแต่ละเรื่องในวารสารวิชาการเล่มนี้เป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับ และบุคคลากรท่านอื่น ๆ ใน สมาคมฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้เขียนแต่ละท่าน หากมีความผิดพลาดใดๆ ผู้เขียนแต่ละท่านจะรับผิดชอบบทความของตนเองแต่ผู้เดียว
